文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India.

作者信息

Dixit Avika, Ektefaie Yasha, Kagal Anju, Freschi Luca, Karyakarte Rajesh, Lokhande Rahul, Groschel Matthias, Tornheim Jeffrey A, Gupte Nikhil, Pradhan Neeta N, Paradkar Mandar S, Deshmukh Sona, Kadam Dileep, Schito Marco, Engelthaler David M, Gupta Amita, Golub Jonathan, Mave Vidya, Farhat Maha

机构信息

Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.

Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Infect Dis. 2025 Feb 4;231(1):84-93. doi: 10.1093/infdis/jiae240.


DOI:10.1093/infdis/jiae240
PMID:38819323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11793027/
Abstract

BACKGROUND: Drivers of tuberculosis (TB) transmission in India, the country estimated to carry a quarter of the world's burden, are not well studied. We conducted a genomic epidemiology study to compare epidemiological success, host factors, and drug resistance among the 4 major Mycobacterium tuberculosis (Mtb) lineages (L1-L4) circulating in Pune, India. METHODS: We performed whole-genome sequencing (WGS) of Mtb sputum culture-positive isolates from participants in two prospective cohort studies and predicted genotypic susceptibility using a validated random forest model. We compared lineage-specific phylogenetic and time-scaled metrics to assess epidemiological success. RESULTS: Of the 612 isolates that met sequence quality criteria, Most were L3 (44.6%). The majority (61.1%) of multidrug-resistant isolates were L2 (P < .001) and L2 demonstrated a higher rate and more recent resistance acquisition. L4 and/or L2 demonstrated higher clustering and time-scaled haplotypic density (THD) compared to L3 and/or L1, suggesting higher epidemiological success. L4 demonstrated higher THD and clustering (odds ratio, 5.1 [95% confidence interval, 2.3-12.3]) in multivariate models controlling for host factors and resistance. CONCLUSIONS: L2 shows a higher frequency of resistance, and both L2 and L4 demonstrate evidence of higher epidemiological success than L3 or L1 in Pune. Contact tracing around TB cases and heightened surveillance of TB DR in India is a public health priority.

摘要

相似文献

[1]
Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India.

J Infect Dis. 2025-2-4

[2]
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.

Genome Med. 2022-8-22

[3]
Phylogenomic assessment of drug-resistant Mycobacterium tuberculosis strains from Beira, Mozambique.

Tuberculosis (Edinb). 2020-3

[4]
A large geno-spatial cluster of multi-drug resistant tuberculosis outbreak in a western district of Thailand.

Infect Genet Evol. 2025-3

[5]
Diversified lineages and drug-resistance profiles of clinical isolates of complex in Malaysia.

Int J Mycobacteriol. 2019

[6]
Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing.

Microbiol Spectr. 2022-2-23

[7]
Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage.

Tuberculosis (Edinb). 2017-12

[8]
Whole-genome sequencing-based genetic diversity, transmission dynamics, and drug-resistant mutations in isolated from extrapulmonary tuberculosis patients in western Ethiopia.

Front Public Health. 2024

[9]
Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.

Microbiol Spectr. 2024-5-2

[10]
Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China.

Antimicrob Resist Infect Control. 2024-10-14

引用本文的文献

[1]
Longitudinal phenotypic and genomic evidence revealing increased risk of drug resistance accumulation in tuberculosis patients in the counties of central China.

Microbiol Spectr. 2025-8-5

本文引用的文献

[1]
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.

Genome Med. 2022-8-22

[2]
Understanding drivers of phylogenetic clustering and terminal branch lengths distribution in epidemics of .

Elife. 2022-6-28

[3]
Tuberculosis Pathways to Care and Transmission of Multidrug Resistance in India.

Am J Respir Crit Care Med. 2022-1-15

[4]
Population structure, biogeography and transmissibility of Mycobacterium tuberculosis.

Nat Commun. 2021-10-20

[5]
GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning.

Genome Med. 2021-8-30

[6]
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.

N Engl J Med. 2021-5-6

[7]
Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India.

Open Forum Infect Dis. 2021-3-4

[8]
Use of a whole genome sequencing-based approach for surveillance in Europe in 2017-2019: an ECDC pilot study.

Eur Respir J. 2021-1-5

[9]
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.

PLoS One. 2020-7-29

[10]
Applied phyloepidemiology: Detecting drivers of pathogen transmission from genomic signatures using density measures.

Evol Appl. 2020-5-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索